China Pharmaceutical Industry Report, 2006-2007
  • Jul/2007
  • Hard Copy
  • USD $299 $150
  • Pages:29
  • Single User License
    (PDF Unprintable)       
  • USD $299 $150
  • Code:
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $598 $299
  • Hard Copy + Single User License
  • USD $499 $250

In Jan-Feb 2007, Product sales revenue of China pharmaceutical industry rose by 17.8% year-on-year and, the gross profits increased by 29.6% from a year earlier.

It is noteworthy that the sales of chemical raw material medicine kept a fast growth and so did the Chinese traditional patent medicine. With the rising price of raw material medicine, the profit also grew rapidly. Besides, there is a sharp increase in the profit of chemical medicine and Chinese traditional patent medicine. Only the growth of the profit of biological medicine was slightly lower than that of the same period of 2006. Except for chemical preparation medicine, the profit margin of each subsidiary industry was all below the level of the year 2006 around, but higher than the same period of last year.

Monthly Sales Income and Growth of Pharmaceutical and Medicine Manufacturing, 2005-2007

Monthly Profits and Growth of Pharmaceutical and Medicine Manufacturing, 2005-2007

Statistical Production/Sales Ratio of Pharmaceutical Industry

1 Operation of Pharmaceutical Industry in 2005-2007 (by Feb)
1.1 Overall Performance
1.2 Subsidiary Industries
1.2.1 Chemical Raw Material Medicine Industry
1.2.2 Chemical Preparation Medicine Industry
1.2.3 Chinese Traditional Patent Medicine
1.2.4 Biological and Biochemical Medicine Industry

2 Major Enterprises Analysis
2.1 Huarun-associated Enterprises
2.1.1 Sanjiu Medical & Pharmaceutical Co., Ltd.
2.1.2 Beijing Double-crane Pharmaceutical Co., Ltd.
2.1.3 Shanghai Pharmaceutical (Group) Co., Ltd.
2.1.3 Beijing Wandong Medical Equipment
2.2 Enterprises with Overall Listing
2.2.1 Beijing Tongrentang (Group) Co., Ltd.
2.2.2 Jiangsu Hengrui Medicine Co., Ltd.
2.2.3 East China Pharmaceutical Co., Ltd.
2.2.4 Zhejiang Hisun Pharmaceutical Co., Ltd.
2.3 Small-category Raw Material Pharmaceutical Enterprises
2.3.1 Hubei Guangji Pharmaceutical Co., Ltd.
2.3.2 Zhejiang Hangzhou Xinfu Pharmaceutical Co., Ltd.
2.4 Others
2.4.1 Zhejiang Huahai Pharmaceutical Co., Ltd.
2.4.2 Shandong Dong-E E-jiao Co., Ltd.
Monthly Sales Income and Growth of Pharmaceutical and Medicine Manufacturing, 2005-2007 (by Feb)
Monthly Profits and Growth of Pharmaceutical and Medicine Manufacturing, 2005-2007 (by Feb)
Profit Margin of Pharmaceutical and Medicine Manufacturing by Month, 2005-2007 (by Feb)
Pharmaceutical Retailing Index in China, 2004-2007 (by Feb)
Statistical Production/Sales Ratio of Pharmaceutical Industry
Structure of Pharmaceutical Sales Revenue in China, Jan-Feb 2007
Structure of Pharmaceutical Profit in China, Jan-Feb 2007
YoY Growth Rate of Pharmaceutical Sales Revenue in China, Jan-Feb 2007
YoY Growth Rate of Pharmaceutical Profit in China, Jan-Feb 2007
Statistics on Pre-tax Profit Margin of Pharmaceutical Products, Jan-Feb 2007
Statistics on Expenditure Rate of Pharmaceutical Period in China, Jan-Feb 2007
Monthly Sales Revenue and Growth of Chemical Raw Material Medicine, 2005-2007 (by Feb)
Monthly Profit and Growth of Chemical Raw Material Medicine, 2005-2007 (by Feb)
Monthly Profit Margin of Chemical Raw Material Medicine, 2005-2007 (by Feb)
Monthly Sales Revenue and Growth of Chemical Preparation Medicine, 2005-2007 (by Feb)
Monthly Profit and Growth of Chemical Preparation Medicine, 2005-2007 (by Feb)
Monthly Profit Margin of Chemical Preparation Medicine, 2005-2007 (by Feb)
Monthly Sales Revenue and Growth of Chinese Traditional Patent Medicine, 2005-2007 (by Feb)
Monthly Profit and Growth of Chinese Traditional Patent Medicine, 2005-2007 (by Feb)
Monthly Profit Margin of Chinese Traditional Patent Medicine, 2005-2007 (by Feb)
Monthly Sales Revenue and Growth of Biological and Biochemical Medicine, 2005-2007 (by Feb)
Monthly Profit and Growth of Biological and Biochemical Medicine, 2005-2007 (by Feb)
Monthly Profit Margin of Biological and Biochemical Medicine, 2005-2007 (by Feb)

China Pharmaceutical Distribution Industry Report, 2019-2025

China’s pharmaceutical distribution industry has sustained steady growth over the years. In 2018, the market was worth RMB2,194.5 billion, a 9.6% rise from RMB2,001.6 billion (up by 8.4% YoY) in 2017,...

China Pharmaceutical Packaging Industry Report, 2019-2025

Being incentivized by the burgeoning pharmaceuticals industry, Chinese pharmaceutical packaging market size sustained growth rates of around 10% in recent years, and outstripped RMB100 billion in 2018...

China Blood Product Industry Report, 2018-2022

The blood product industry in China develops under stimulation of industry policies and downstream demand. The country recorded total lot release volume of 64.11 million bottles of blood products in 2...

China Pharmaceutical Distribution Industry Report, 2017-2021

The Chinese pharmaceutical distribution market has developed steadily but at a slower rate in recent years. The industry rose by 10.4% year on year to RMB1.8393 trillion in 2016 and is expected to hit...

China Blood Product Industry Report, 2017-2021

China’s blood product market size mushroomed in 2016 under the impetus of liberalization of limited-price policy, price rises in varying degrees and lot release volume growth for blood products in 201...

China Pharmaceutical Packaging Industry Report, 2016-2021

Under the impetus of the fast-growing downstream pharmaceutical industry, Chinese pharmaceutical packaging market size increased year by year at the CAGR of 11.2% during 2010-2016. From 2017 to 2021, ...

China Pharmaceutical Glass Packaging Industry Report, 2014-2017

In recent years, advances in new healthcare reform have boosted market demand from China pharmaceuticals industryand driven growth in the demand from pharmaceutical packaging industry. In 2014, the Ch...

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

China Pharmaceutical Equipment Industry Report, 2012-2015

Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over ...

China Genetic Engineering Drug Industry Report, 2011-2012

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

China Animal Vaccine Industry Report, 2011-2012

Along with the frequent outbreaks of animal epidemics, the government’s increasing investment in epidemic prevention and the implementation of compulsory immunization system, Chinese animal vaccine ma...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号